We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.51B
1-Year Est. Return 25.86%
This Fund
S&P 500
This Quarter Est. Return
-2.55%
1 Year Est. Return
+25.86%
3 Year Est. Return
+100.08%
5 Year Est. Return
+137.58%
10 Year Est. Return
AUM
$1.51B
AUM Growth
-$1.12B
Cap. Flow
-$1.06B
Cap. Flow %
-70.31%
Top 10 Hldgs %
38.41%
Holding
452
New
24
Increased
51
Reduced
230
Closed
119

Sector Composition

1 Technology 20.75%
2 Healthcare 13.86%
3 Industrials 9.36%
4 Consumer Discretionary 8.46%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYL icon
51
Xylem
XYL
$29.2B
$7.21M 0.48%
60,290
+476
+0.8% +$62.4K
LIVN icon
52
LivaNova
LIVN
$4.43B
$7.15M 0.47%
112,524
-1,934
-2% -$125K
CSCO icon
53
Cisco
CSCO
$441B
$6.31M 0.42%
81,319
-174,496
-68% -$13.7M
RTX icon
54
RTX Corp
RTX
$261B
$6.16M 0.41%
31,957
-57,515
-64% -$11.4M
BX icon
55
Blackstone
BX
$155B
$5.96M 0.4%
51,821
-16,262
-24% -$2.12M
LMT icon
56
Lockheed Martin
LMT
$117B
$5.61M 0.37%
9,290
-233
-2% -$144K
ORCL icon
57
Oracle
ORCL
$364B
$5.51M 0.37%
37,458
-23,385
-38% -$3.8M
TJX icon
58
TJX Companies
TJX
$171B
$5.46M 0.36%
34,186
-101
-0.3% -$15.7K
ABBV icon
59
AbbVie
ABBV
$450B
$5.4M 0.36%
24,829
-38,833
-61% -$8.61M
UNP icon
60
Union Pacific
UNP
$179B
$5.1M 0.34%
21,017
-107
-0.5% -$26.2K
EPD icon
61
Enterprise Products Partners
EPD
$82.6B
$5.09M 0.34%
134,431
-300
-0.2% -$10.6K
ECL icon
62
Ecolab
ECL
$76.8B
$5.07M 0.34%
19,056
+46
+0.2% +$13K
SYRE icon
63
Spyre Therapeutics
SYRE
$8.7B
$5.02M 0.33%
99,460
-4,258
-4% -$161K
GH icon
64
Guardant Health
GH
$20.7B
$5M 0.33%
54,180
-4,387
-7% -$440K
UTHR icon
65
United Therapeutics
UTHR
$22.7B
$4.97M 0.33%
8,384
+784
+10% +$390K
TVTX icon
66
Travere Therapeutics
TVTX
$5.27B
$4.9M 0.33%
164,990
-3,426
-2% -$102K
NUE icon
67
Nucor
NUE
$53.9B
$4.75M 0.32%
28,100
-93
-0.3% -$16.2K
HCA icon
68
HCA Healthcare
HCA
$82.3B
$4.74M 0.31%
10,013
-232
-2% -$117K
MIRM icon
69
Mirum Pharmaceuticals
MIRM
$7.25B
$4.7M 0.31%
50,911
-2,177
-4% -$205K
VIOO icon
70
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.17B
$4.58M 0.3%
39,922
KALV
71
DELISTED
KalVista Pharmaceuticals
KALV
$4.57M 0.3%
226,991
-9,699
-4% -$156K
WMT icon
72
Walmart Inc
WMT
$909B
$4.53M 0.3%
36,430
-60,730
-63% -$7.46M
NKTR icon
73
Nektar Therapeutics
NKTR
$2.31B
$4.4M 0.29%
61,104
+2,981
+5% +$170K
ZMUN
74
F/m Ultrashort Tax-Free Municipal ETF
ZMUN
$33.3M
$4.38M 0.29%
87,437
-6,891
-7% -$346K
BBIO icon
75
BridgeBio Pharma
BBIO
$15.9B
$4.05M 0.27%
54,599
+3,427
+7% +$248K

Similar funds

F/M Investments's Q1 2026 Portfolio in Review

As of Q1 2026, F/M Investments held 452 positions worth $1.51B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

F/M Investments withdrew a net $1.06B in Q1 2026, closing 119 positions and reducing 230 holdings. Its most notable exit was Vanguard FTSE Emerging Markets ETF, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, F/M Investments opened a new position in Dimensional Core Fixed Income ETF worth $128M.

  • F/M Investments's largest Q1 2026 buy was Dimensional Core Fixed Income ETF: 3,036,000 shares worth $128M.
  • F/M Investments added most to Vanguard FTSE All-World ex-US ETF in Q1 2026, an estimated $46M increase.
  • F/M Investments's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $57.6M.
  • F/M Investments fully exited Vanguard FTSE Emerging Markets ETF in Q1 2026, selling an estimated $17.8M.
  • F/M Investments's ten largest holdings make up 38% of its $1.51B portfolio in Q1 2026.
  • F/M Investments opened 24 new positions and closed 119 in Q1 2026.
  • F/M Investments's portfolio value fell 43% quarter-over-quarter to $1.51B.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.